UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The anti-tumor effect of RANKL inhibition in malignant solid tumors – A systematic review

Cancer treatment reviews, 2018-01, Vol.62, p.18-28

2018

Volltextzugriff (PDF)

Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854)

Breast cancer research and treatment, 2013-06, Vol.139 (2), p.371-379

2013

Volltextzugriff (PDF)

Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy

Gynecologic oncology, 2014-11, Vol.135 (2), p.231-238

2014

Volltextzugriff (PDF)

CDK4/6 inhibition in early and metastatic breast cancer: A review

Cancer treatment reviews, 2017-11, Vol.60, p.130-138

2017

Volltextzugriff (PDF)

First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study

Annals of oncology, 2011-01, Vol.22 (1), p.207-214

2011

Volltextzugriff (PDF)

Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer

Cancer treatment reviews, 2011-10, Vol.37 (6), p.422-430

2011

Volltextzugriff (PDF)

Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)

Gynecologic oncology, 2022-05, Vol.165 (2), p.223-229

2022

Volltextzugriff (PDF)

The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy

Breast cancer research and treatment, 2023-10, Vol.201 (3), p.471-478

2023

Volltextzugriff (PDF)

Systematic review of the clinical and economic value of gene expression profiles for invasive early breast cancer available in Europe

Cancer treatment reviews, 2018-01, Vol.62, p.74-90

2018

Volltextzugriff (PDF)

Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome

Annals of oncology, 2007-10, Vol.18 (10), p.1745-1747

2007

Volltextzugriff (PDF)

Higher ER load is not associated with better outcome in stage 1–3 breast cancer: a descriptive overview of quantitative HR analysis in operable breast cancer

Breast cancer research and treatment, 2019-07, Vol.176 (1), p.27-36

2019

Volltextzugriff (PDF)

Gene expression signatures in older patients with breast cancer: A systematic review

Critical reviews in oncology/hematology, 2023-01, Vol.181, p.103884-103884, Article 103884

2023

Volltextzugriff (PDF)

Reliability of core needle biopsy for determining ER and HER2 status in breast cancer

Annals of oncology, 2013-04, Vol.24 (4), p.931-937

2013

Volltextzugriff (PDF)

Neoadjuvant hormonal therapy for endocrine sensitive breast cancer: A systematic review

Cancer treatment reviews, 2014-02, Vol.40 (1), p.86-92

2014

Volltextzugriff (PDF)

Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial

European journal of cancer (1990), 2014-12, Vol.50 (18), p.3077-3088

2014

Volltextzugriff (PDF)

Advances in epithelial ovarian cancer therapy

Current pharmaceutical design, 2012, Vol.18 (25), p.3735

Kroep, J R

2012

Volltextzugriff (PDF)

The prognostic role of TGF-β signaling pathway in breast cancer patients

Annals of oncology, 2013-02, Vol.24 (2), p.384-390

2013

Volltextzugriff (PDF)

Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy

Breast cancer research and treatment, 2019-06, Vol.175 (3), p.605-615

2019

Volltextzugriff (PDF)

Cross-cultural comparison of breast cancer patients’ Quality of Life in the Netherlands and Japan

Breast cancer research and treatment, 2017-11, Vol.166 (2), p.459-471

2017

Volltextzugriff (PDF)

Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials

European journal of cancer (1990), 2016-02, Vol.54, p.57-63

2016

Volltextzugriff (PDF)

Oncologist, patient, and companion questions during pretreatment consultations about adjuvant cancer treatment: a shared decision‐making perspective

Psycho-oncology (Chichester, England), 2017-07, Vol.26 (7), p.943-950

2017

Volltextzugriff (PDF)

Chemotherapy resistance and stromal targets in breast cancer treatment: a review

Molecular biology reports, 2020-10, Vol.47 (10), p.8169-8177

2020

Volltextzugriff (PDF)

Extended adjuvant endocrine therapy in hormone-receptor positive early breast cancer: Current and future evidence

Cancer treatment reviews, 2015-03, Vol.41 (3), p.271-276

2015

Volltextzugriff (PDF)

The blood mMDSC to DC ratio is a sensitive and easy to assess independent predictive factor for epithelial ovarian cancer survival

Oncoimmunology, 2018-01, Vol.7 (8), p.e1465166-e1465166

2018

Volltextzugriff (PDF)

1 – 25 von 324

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(262)
Mit Volltextzugriff
(291)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(154)
Life Sciences & Biomedicine
(149)
Humans
(137)
Female
(120)
Oncology
(118)
Breast Cancer
(77)
Middle Aged
(66)
Aged
(58)
Adult
(52)
Chemotherapy
(52)
Breast Neoplasms - Drug Therapy
(46)
Tumors
(39)
Breast Neoplasms - Pathology
(34)
Treatment Outcome
(34)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(33)
Patients
(31)
Prognosis
(30)
Cancer Therapies
(28)
Biological And Medical Sciences
(27)
Cancer
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

The anti-tumor effect of RANKL inhibition in malignant solid tumors – A systematic review

Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854)

Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy

CDK4/6 inhibition in early and metastatic breast cancer: A review

First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study

Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer

Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)

The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy

Systematic review of the clinical and economic value of gene expression profiles for invasive early breast cancer available in Europe

p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial

Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome

Higher ER load is not associated with better outcome in stage 1–3 breast cancer: a descriptive overview of quantitative HR analysis in operable breast cancer

Gene expression signatures in older patients with breast cancer: A systematic review

Reliability of core needle biopsy for determining ER and HER2 status in breast cancer

Neoadjuvant hormonal therapy for endocrine sensitive breast cancer: A systematic review

Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial

Advances in epithelial ovarian cancer therapy

The prognostic role of TGF-β signaling pathway in breast cancer patients

Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy

Cross-cultural comparison of breast cancer patients’ Quality of Life in the Netherlands and Japan

Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials

Oncologist, patient, and companion questions during pretreatment consultations about adjuvant cancer treatment: a shared decision‐making perspective

Chemotherapy resistance and stromal targets in breast cancer treatment: a review

Extended adjuvant endocrine therapy in hormone-receptor positive early breast cancer: Current and future evidence

The blood mMDSC to DC ratio is a sensitive and easy to assess independent predictive factor for epithelial ovarian cancer survival

Suchergebnisse filtern